help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 5, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2123
A more recent version of this article appeared on February 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
92/2/705    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wood, J. R.
Right arrow Articles by Strauss, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wood, J. R.
Right arrow Articles by Strauss, J. F., III

Submitted on September 28, 2006
Accepted on November 28, 2006

Molecular Abnormalities in Oocytes from Women with Polycystic Ovary Syndrome Revealed by Microarray Analysis

Jennifer R. Wood*, Daniel A. Dumesic, David H. Abbott, and Jerome F. Strauss III

Department of Animal Science, University of Nebraska, Lincoln, NE 68583 USA; National Primate Research Center and Department of OB/GYN, University of Wisconsin, Madison, WI 53715 USA; Mayo Clinic, Rochester, MN, 55905 and Reproductive Medicine and Infertility Associates, Woodbury, MN 55125 USA; Department of OB/GYN, Virginia Commonwealth University, Richmond, VA 23298 USA

* To whom correspondence should be addressed. E-mail: jwood5{at}unl.edu.

Context: Polycystic ovary syndrome (PCOS), the most common cause of anovulatory infertility, is characterized by increased ovarian androgen production, arrested follicle development, and is frequently associated with insulin resistance. These PCOS phenotypes are associated with exaggerated ovarian responsiveness to FSH and increased pregnancy loss.

Objective: To examine whether the perturbations in follicle growth and the intrafollicular environment affects gene expression and ultimately development of the PCOS oocyte.

Design: Oocyte cDNA was subjected to microarray and PCR analysis.

Setting: University laboratory.

Patients: Ten normal ovulatory and nine PCOS women.

Intervention: GnRH analog/ rhFSH therapy for IVF.

Main Outcome Measures: mRNA abundance of oocyte-expressed genes.

Results: Cluster analysis revealed differences in global gene expression profiles between normal and PCOS oocytes. Of the 8123 transcripts expressed in the oocytes, 374 genes showed significant differences in mRNA abundance in PCOS oocytes. Annotation of the data demonstrated that a subset of these genes was associated with chromosome alignment and segregation during mitosis and/or meiosis. Furthermore, 68 of the differentially expressed genes contained putative androgen receptor and/or peroxisome proliferating receptor gamma binding sites.

Conclusions: These analyses demonstrated that normal and PCOS oocytes that are morphologically indistinguishable and of high quality exhibit different gene expression profiles. Promoter analysis suggests that androgens and other activators of nuclear receptors may play a role in differential gene expression in the PCOS oocyte. Likewise, annotation of the differentially expressed genes suggests that defects in meiosis or early embryonic development may contribute to reduced developmental competency of PCOS oocytes.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
S. Franks, J. Stark, and K. Hardy
Follicle dynamics and anovulation in polycystic ovary syndrome
Hum. Reprod. Update, May 22, 2008; (2008) dmn015v1.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
T. Hamatani, M. Yamada, H. Akutsu, N. Kuji, Y. Mochimaru, M. Takano, M. Toyoda, K. Miyado, A. Umezawa, and Y. Yoshimura
What can we learn from gene expression profiling of mouse oocytes?
Reproduction, May 1, 2008; 135(5): 581 - 592.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.O. Goodarzi, N. Xu, J. Cui, X. Guo, Y.I. Chen, and R. Azziz
Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome
Hum. Reprod., May 1, 2008; 23(5): 1214 - 1219.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society